Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland.
about
Outcomes after viral load rebound on first-line antiretroviraltreatment in children with HIV in the UK and Ireland: an observational cohort studyHigh levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children.Adolescents with HIV and transition to adult care in the Caribbean, Central America and South America, Eastern Europe and Asia and Pacific regions.Virologic Response to First-line Efavirenz- or Nevirapine-based Antiretroviral Therapy in HIV-infected African Children.Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets.Suboptimal Viral Suppression Rates Among HIV-Infected Children in Low- and Middle-Income Countries: A Meta-analysis.Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life.Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries.Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and ThailandBritish HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
P2860
Q36087922-77FB7640-F91C-4FFC-94D4-39789B5D8490Q37410105-C139F3C0-4081-4789-9F0F-28E45A2BF688Q38681064-C5DD1E3D-19AF-4637-AD2F-FC2777C40BD6Q38850249-03A00909-7B6B-40DC-9A49-D2A40317C109Q38851687-7CAD49AA-B1BA-4455-9BC1-6F1E5721C66EQ38913065-DAAB9A0E-6930-4B54-9E30-339495C49728Q41505058-EDA955F8-1ADF-4B8E-A432-90B025612CD8Q45326130-9C945E9C-8D59-49A7-8C2A-E12DC12C99D5Q47404336-1D8BC444-F854-47F1-9FC6-1866AC8EA836Q57077691-38935638-1052-4911-BA4E-F0A9E12E2018Q57180790-57DF81FF-6115-4853-8EFE-E5694BE0A7BE
P2860
Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Long-term virological outcome ...... therapy in the UK and Ireland.
@ast
Long-term virological outcome ...... therapy in the UK and Ireland.
@en
Long-term virological outcome ...... therapy in the UK and Ireland.
@nl
type
label
Long-term virological outcome ...... therapy in the UK and Ireland.
@ast
Long-term virological outcome ...... therapy in the UK and Ireland.
@en
Long-term virological outcome ...... therapy in the UK and Ireland.
@nl
prefLabel
Long-term virological outcome ...... therapy in the UK and Ireland.
@ast
Long-term virological outcome ...... therapy in the UK and Ireland.
@en
Long-term virological outcome ...... therapy in the UK and Ireland.
@nl
P2093
P2860
P1433
P1476
Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland
@en
P2093
Caroline Foster
Collaborative HIV Paediatric Study Steering Committee
David T Dunn
Delane Shingadia
Esse Menson
Hermione Lyall
Karina Butler
Katja Doerholt
P2860
P304
P356
10.1097/QAD.0000000000000438
P407
P577
2014-10-01T00:00:00Z